Literature DB >> 31813640

The emergence of Staphylococcus epidermidis simultaneously nonsusceptible to linezolid and teicoplanin in China.

Cailin Liu1, Chunguang Chen2, Yafei Ye1, Xiaogai Li1, Jingjing Sun1, Lijuan Xu1, Liang Ming3.   

Abstract

Two linezolid-resistant and teicoplanin-intermediate Staphylococcus epidermidis strains were isolated from blood cultures in China. The 2 S. epidermidis strains were methicillin-resistant and showed multidrug-resistance patterns; in addition, population analysis profiling/area under the curve (PAP/AUC) result showed heterogeneous resistant to vancomycin. Comparing to teicoplanin susceptible strains, the 2 isolates showed reduced autolytic activity. Pulsed field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) indicated that the 2 S. epidermidis isolates belonged to the same clone. Furthermore, the cfr gene, a G2576T mutation, and a novel C2146T mutation were detected in the 2 isolates. This was the first report of S. epidermidis simultaneously nonsusceptible to linezolid and teicoplanin in China.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Linezolid-resistant; Staphylococcus epidermidis; Teicoplanin-intermediate; cfr gene

Mesh:

Substances:

Year:  2019        PMID: 31813640     DOI: 10.1016/j.diagmicrobio.2019.114956

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  2 in total

1.  Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria.

Authors:  Stefan Schwarz; Wanjiang Zhang; Xiang-Dang Du; Henrike Krüger; Andrea T Feßler; Shizhen Ma; Yao Zhu; Congming Wu; Jianzhong Shen; Yang Wang
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

2.  [Methicillin-resistant Staphylococcus epidermidis infectious keratitis: Clinical and microbiological profile].

Authors:  L Vidal Oliver; P Bayo Calduch; L Forqué Rodríguez; D Navarro Ortega; A M Duch Samper; J Colomina Rodríguez
Journal:  Rev Esp Quimioter       Date:  2022-01-24       Impact factor: 1.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.